Kjær Group - Cluster for Molecular Imaging

We focus on translational molecular imaging with PET and PET/MRI and on development of targeted radionuclide therapies (theranostics) for use in precision medicine in cancer, cardiovascular diseases and inflammatory disease.

Research

 

For practice of precision medicine, non-invasive tools for diagnosing and prognostication at the molecular level are needed. Molecular imaging methods are capable of this while at the same time circumventing sampling error as the whole tumor burden is evaluated.

We have expertise in all the steps involved in developing molecular imaging: from basic research to obtaining approval by the health authorities, GMP and GCP. Access to both clinical and preclinical state-of-the-art facilities allow us to perform highly translational research based on relevant clinical challenges. Several of our results have been implemented in clinical routine. 

 

 

The group is headed by Professor Andreas Kjær (MD, PhD, DMSc). Development of molecular imaging involves numerous disciplines; therefore, the group includes researchers from diverse backgrounds: physicists, chemists, engineers, human biologists, medical doctors, veterinarians, etc. We value a friendly, yet ambitious working environment where researchers can interact both professionally and socially.

 

 

Daniel Dawson Murray
daniel.murray@sund.ku.dk

 

Group members

This content is temporarily unavailable because the system it is fetched from cannot be reached. The rest of the site works as usual.

Status is available on the operating status page.

Andreas Kjær forskerprofil

Group Leader

Andreas Kjær
Professor 

Phone +453532 7504
akjaer@sund.ku.dk

ORCID: 0000-0002-2706-5547